ABSTRACT. Brucella, an intracellular parasite that infects some livestock and humans, can damage or destroy the reproductive system of livestock. The syndrome is referred to as brucellosis and often occurs in pastoral areas; it is contagious from livestock to humans. In this study, the intact Brucella suis outer membrane protein 31 (omp31) gene was cloned, recombinantly expressed, and examined as a subunit vaccine candidate. The intact Brucella lumazine synthase (bls) gene was cloned and recombinantly expressed to study polymerization function in vitro. Non-reducing gel electrophoresis showed that rBs-BLS existed in different forms in vitro, including as a dimer and a pentamer. An enzyme-linked immunosorbent assay result showed that rOmp31 protein could induce production of an antibody in rabbits. However, the rOmp31-BLS fusion protein could elicit a much higher antibody titer in rabbits; this construct involved fusion of the Omp31 molecule with the BLS molecule. Our results indicate that Omp31 is involved in immune stimulation, while BLS has a polymerizing function based on rOmp31-BLS fusion protein immunogenicity. These data 13085 BLS promotes immune-stimulation effects of antigens ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 14 (4): 13084-13095 (2015) suggest that Omp31 is an ideal subunit vaccine candidate and that the BLS molecule is a favorable transport vector for antigenic proteins.
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INTRODUCTION
Brucellosis is one of the world's major zoonoses and is a highly contagious bacterial disease induced by Brucella, an intracellular parasite. Once livestock are infected by Brucella, the reproductive system is damaged, resulting in concomitant loss in productivity of affected animals (Miraglia et al., 2013) , causing large economic losses. Additionally, Brucella infection is a serious threat to human health and wildlife populations. Animals and their food products are the primary source of human infection; mucosal routes are the most common modes of transmission through inhalation and ingestion of animal-derived contaminated materials, respectively. Brucellosis is one of the most common zoonotic diseases, with an estimated annual incidence of 500,000 cases (Avila-Calderón et al., 2013) . The situation is particularly severe in underdeveloped countries.
Brucella has been found in various animals, including cow, goat, dog, and pig, among others. Current research has shown that the genus Brucella includes at least 12 species, which are identified and divided according to host specificity and the ability to cause chronic infections in animals and humans (Muñoz et al., 2006) . The 12 species of genus Brucella are Brucella abortus, B. melitensis, B. suis, B. ovis, B. canis, B. neotomae, B. microti, B. inopinata, B. pinnipedialis, B. ceti, and 2 additional species (nonhuman primates Brucella and foxes Brucella) (Godfroid et al., 2010) . Notably, B. abortus, B. melitensis, and B. suis are responsibly for infection in animals and humans. Most Brucella species are associated primarily with specific hosts, possibly because of evolutionary adaptation. For instance, B. canis is the causative agent of canine brucellosis, which results in contagious abortion, uveitis, and orchiepididymitis. However, B. canis rarely causes human brucellosis (Chen et al., 2014) . Transmission to humans occurs only through close contact with infected animals or bacterial cultures. B. melitensis mainly affects goats and sheep but can also infect cattle and cause severe placentitis. B. abortus is the most widespread, causing abortion in cattle and chronic infection in humans. B. suis infects a broad range of animals, including swine, reindeer, caribou, hares, various murine species, and, occasionally, cattle and dogs (Dean et al., 2012) . Additionally, a different genus of Brucella may also infect different animals or humans. Although each species exhibit host preference, cross-species infections frequently occur. For example, B. canis mostly infects dogs but can also infect cattle (Yüksekkaya et al., 2013) . B. melitensis is mostly limited to goats but can also infect swine (Mermer et al., 2013) .
At the beginning of 20th century, studies attempted to identify a Brucella vaccine to prevent brucellosis in animals and humans (Cassataro et al., 2005a) . For the prevention and control of brucellosis, live vaccines remain the main strategy examined. Nevertheless, modified live vaccines have been shown to possess superior protective immunogenic activity (Schurig et al., 2002 (Yang et al., 2013) . Although these live and modified live vaccines are available for livestock to prevent brucellosis, their immunization programs must be maintained to limit human infection (Denisov et al., 2010) . Previous studies have shown that vaccination of uninfected animals and some infected animals successfully eradicated brucellosis. However, there is no vaccine for humans, and thus animal vaccination remains a critical factor for the control and eradication of brucellosis in animals and humans. However, with the use of live vaccines in livestock, Brucella toxicity reversion often occurs (Gomez et al., 2013) . Additionally, because live vaccines may cause infection in humans and resistance to antibiotics used to treat brucellosis may develop, and thus health officials have prohibited their use in human vaccination. Thus, better vaccines for livestock and humans should be developed to overcome these limitations. There is increasing interest in the immunogenicity and protective effects of Brucella outer membrane proteins (OMPs) and cytoplasmic proteins (Pollak et al., 2012) . The subunit vaccines mainly include recombinant proteins, vectored vaccines, DNA vaccines, and outer membrane vesicles, among others (Cassataro et al., 2005b) . Subunit vaccines are preferred over the use of the live-attenuated vaccines because live vaccines may revert to a virulent state, cause abortion in pregnant animals, and become dispersed in milk.
Bacterial cell surface proteins antigens are good vaccine candidates because they represent the initial contact point between the pathogen and host. Numerous subunit fractions from Brucella have been examined as recombinant proteins as vaccines in a mouse model, and some have shown good protective effects (Kaushik et al., 2010) . Some Brucella immunogenic antigens are located on the outer membrane of this gram-negative pathogen. These proteins include Omp31, Omp28, and Omp25, among others. Omp31 molecule is regarded to be a superior recombinant protein candidate for subunit vaccine and originated from Brucella. Omp31 elicited different immune responses to protect the host against B. ovis in BALB/c mice and rams (Luo et al., 2006) . Additionally, the Brucella lumazine synthase (BLS) enzyme is a highly immunogenic protein that functions as a decameric protein (Estein et al., 2009) . When a foreign antigenic protein was covalently attached to BLS molecules, the protein's immune-stimulation effect greatly increased .
In this study, we used the Brucella BLS intact molecule and Omp31 intact molecule to examine 2 questions. We examined whether the Brucella BLS intact molecule possessed polymerization function by using a reformative non-reducing sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) method. Additionally, we determined whether the fusion protein molecule (Omp31-BLS) possessed superior immunogenicity compared to the Omp31 molecule by using western blotting and enzyme-linked immunosorbent assay (ELISA) techniques.
MATERIAL AND METHODS

Bacterial culture
B. suis S2 was grown overnight in 10 mL tryptic soy broth with constant agitation at 37°C for 16 h. Bacterial sediment was collected by centrifugation for 10 min at 4000 g at 4°C. The bacterial sediment was used for genome DNA extraction using a total genome DNA extraction kit (Shanghai Sangon, Shanghai, China). All procedures were performed in a biological safety cabinet in a special laboratory.
Target gene cloning
When first target bls gene was cloned, specific forward and reverse primers (F1: 5'-CCG GAA TTC ATG AAC CAA AGC TGT CCG AAC-3'; R1: 5'-CCG CTC GAG TCA GAC AAG CGC GGC GAT GC-3') were designed to clone the intact DNA sequence. Using B. suis S2 total genomic DNA as template, polymerase chain reaction (PCR) amplification was carried out as follows: 94°C for 3 min; 35 cycles of 94°C for 30 s, 53°C for 45 s, and 72°C for 30 s; extension at 72°C for 5 min. PCR products were in-gel purified using the gel purification kit (Shanghai Sangon) following the manufacturer instructions. This was followed by ligation into the pET-28a vector (TaKaRa, Shiga, Japan) and transformation into competent DH5α cells. The positive recombinants were identified on kanamycin-containing LB plates and by PCR screening using 2 specific primers, F1 and R1. Positive clones were sequenced by Shanghai Sangon.
When the second target omp31 antigenic gene was cloned, specific forward and reverse primers (F2: 5'-CCG GAA TTC ATG AAG TCC GTA ATT TTG GCG-3'; R2: 5'-CCG CTC GAG TTA GAA CTT GTA GTT CAG-3') were designed to clone the gene intact DNA sequence. Using B. suis S2 total genomic DNA as template, PCR amplification was carried out as follows: 94°C for 3 min; 35 cycles of 94°C for 30 s, 57°C for 45 s, and 72°C for 40 s; extension at 72°C for 5 min. PCR products were in-gel purified using a gel purification kit following the manufacturer instructions. This was followed by ligation into the pGEX-4T-1 vector (TaKaRa) and transformation into competent DH5α cells. Positive recombinants were identified on ampicillin-containing LB plates and by PCR screening using 2 specific primers, F2 and R2. Positive clones were sequenced by Shanghai Sangon.
When the third target omp31-bls fusion gene was cloned, 2 pairs of specific forward and reverse primers (F3: 5'-CCG GAA TTC ATG AAG TCC GTA ATT TTG GCG-3'; R3: 5'-GTT CGG ACA GCT TTG GTT CAT GAA CTT GTA GTT CAG ACC G-3' and F4: 5'-CGG TCT GAA CTA CAA GTT CAT G AA CCA AAG CTG TCC GAA C-3'; R4: 5'-CCG CTC GAG TCA GAC AAG CGC GGC GAT G -3') were designed to clone the fusion gene DNA sequence. Using B. suis S2 total genomic DNA as template, the first PCR amplification was carried out using F3 and R3, as follows: 94 °C for 3 min; 35 cycles of 94°C for 30 s, 61°C for 45 s, and 72°C for 45 s; extension at 72°C for 5 min. The second PCR amplification was carried out using F4 and R4, as follows: 94°C for 3 min; 35 cycles of 94°C for 30 s, 59°C for 45 s, and 72°C for 40 s; extension at 72°C for 5 min. The 2 PCR products were in-gel purified using a gel purification kit (Shanghai Sangon) following the manufacturer instructions. Subsequently, 2 µL purified PCR products was used as a template for the third PCR, using F3 and R4 as primers. The procedure was as follows: 94°C for 3 min; 35 cycles of 94°C for 30 s, 61°C for 45 s, and 72°C for 60 s; extension at 72°C for 10 min. PCR products were also in-gel purified using a gel purification kit following the manufacturer instructions. This was followed by ligation into the pET-28a vector (TaKaRa) and transformation into competent DH5α cells. Positive recombinants were identified on kanamycin-containing LB plates and PCR screening using 2 specific primers, F3 and R4. Positive clones were sequenced by Shanghai Sangon. After sequencing, the 3 positive clones were stored at -80°C until use.
Recombinant expression, purification, and antiserum preparation
Recombinant expression was conducted as follows. The pET-28-a expression vector carrying the target gene was transformed into competent Escherichia coli BL21(DE3) expression bacteria with kanamycin resistance for recombinant expression. Subsequent purification steps used His Bind resin chromatography (Novagen, Billerica, MA, USA). The pGEX-4T-1 expression vector carrying the target gene was transformed into competent E. coli BL21 expression bacteria with ampicillin resistance for recombinant expression. Subsequent purification work used Glutathione Sepharose 4B chromatography (Novagen).
Next, 3 mL transformants cultured overnight were transferred into 300 mL Luria-Bertani broth containing kanamycin or ampicillin for large-scale culture. When the OD 600 value reached 0.6, 0.5 mM isopropyl β-D-1-thiogalactopyranoside was added to induce target recombinant protein expression. After culturing at 37°C for 3 h, the bacteria were collected by centrifugation at 4000 g for 5 min and re-suspended in 20 mL 1X phosphate-buffered saline (PBS) containing 0.2% Triton X-100. The bacteria collected were lysed by ultrasonication. The soluble fraction was used for protein purification. The target recombinant protein was respectively purified by His Bind resin chromatography or Glutathione Sepharose 4B chromatography following the manufacturer instructions. Purified recombinant protein was stored at -80°C until use.
Purified recombinant protein was used as protein antigen to produce polyclonal rabbit antiserum using a previously described method (Du et al., 2010) . The His or GST tag was removed from recombinant proteins using thrombin before injection into animals. The purified recombinant protein was briefly re-isolated by SDS-PAGE. The area of the gel containing the sample band was homogenized with 1 mL saline and mixed with 1 mL complete Freund's adjuvant. The thoroughly mixed samples were subcutaneously injected into the rabbits once per week for 3 weeks. Subsequently, 100 µg highly purified recombinant protein was injected without adjuvant once weekly for 6 weeks through a vein along the edge of the ear. Blood samples were collected to perform western blot analysis after the last booster.
Western blot analysis
Western blot analysis was performed to investigate the immunogenicity of 3 recombinant proteins. Proteins used for SDS-PAGE samples included recombinant rBLS, rOmp31, and rOmp31-BLS. These proteins were then electrically transferred onto a nitrocellulose membrane. Proteins bands were detected using corresponding rabbits antiserum in an immunoblotting assay.
Polymerization of rBLS molecule in vitro
Reformative non-reducing SDS-PAGE was used to detect the polymerization of the rBLS molecule in vitro. Boiling and β-mercaptoethanol were used for non-reducing SDS-PAGE. For the first group, β-mercaptoethanol was not included. For the second group, boiling was not conducted. For the third group, boiling was not conducted and β-mercaptoethanol was not included. Proteins from the 3 groups were electrically transferred onto a nitrocellulose membrane at the same time. Proteins bands were detected using corresponding rabbits antiserum in an immunoblotting assay.
ELISA detection of rOmp31 and rOmp31-BLS antiserum
To estimate the immune stimulatory effects of different antigens, an ELISA assay was performed to detect the antibody titer. Briefly, ELISA 96-well plates were coated with 100 µL 100 µg/mL rOmp31 solution or 100 µg/mL rOmp31-BLS solution. The antigen protein solution was diluted with 0.05 M sodium carbonate solution, pH 9.6. The control sample was 100 μL 1X PBS. Samples were incubated overnight at room temperature. The plates were then washed 5 times with 1X PBS containing 0.05% Tween-20 (PBST) for 3 min each time. Next, 200 µL 10% bovine serum albumin in PBST was plated and incubated for 2 h at room temperature. ELISA was then performed using 1:1000 dilutions of either immunized rabbit serum. The plates were again washed 5 times with PBST. Next, 100 µL horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (Shanghai Sangon) (diluted 1:1000 with 1X PBS) was added to each well of the plate. The plates were again incubated for 1 h at room temperature. The plates were then washed 5 times with PBST. Subsequently, 100 µL substrate (OPD-H 2 O 2 ) was dispensed into each well. Ten minutes later, the reaction was stopped by adding 50 µL 20% H 2 SO 4 . An ELISA microplate reader was used to read the absorbance at 492 nm. This experiment was repeated 3 times. The data obtained were statistically analyzed followed by an unpaired sample t-test. Significant difference was accepted at P < 0.05. Extremely significant differences were accepted at P < 0.01.
RESULTS
cDNA sequences of bls gene and omp31 gene
The intact cDNA sequences of the B. suis bls gene and omp31 gene were obtained after sequencing and assembly. Both 477-bp and a 723-bp open reading frame fragments were cloned. After BLAST online analysis, we chose 1 gene as the B. suis bls gene, referred to as Bs-bls, while the other gene was B. suis omp31, referred to as Bs-omp31. The open reading frame of Bs-bls encoded 158 amino acid residues, which did not contain the signal peptide sequence (Figure 1) . The open reading frame of Bs-omp31 encoded 240 amino acid residues and did not contain the signal peptide sequence (Figure 2) . 
Recombinant expression and purification of rBs-BLS, rBs-Omp31, and rBsOmp31-BLS
After expression induction, recombinant rBs-BLS, rBs-Omp31, and rBs-Omp31-BLS were correctly expressed in the E. coli recombinant expression system. The theoretically predicted molecular mass of rBs-BLS was 21 kDa, which includes the molecular mass of the His-tag (5.6 kDa). The SDS-PAGE results (Figure 3) showed that the target band of rBs-BLS was consistent with the theoretical value. Western blot analysis (Figure 4 ) revealed that this protein band was recognized by the polyclonal antibody produced by rabbit after injection with purified rBs-BLS (without His-tag). The theoretically predicted molecular mass of rBs-Omp31 was 55.3 kDa, which includes the molecular mass of the GST-tag (25 kDa). The SDS-PAGE results ( Figure 5A ) showed that the target band of rBs-Omp31 was consistent with the theoretical value. Western blot analysis showed that this protein band was recognized by the polyclonal antibody produced in rabbits after injection with purified rBs-BLS (without GST-tag) ( Figure 5B ). Additionally, the theoretically predicted molecular mass of fusion rBs-Omp31-BLS was 49.4 kDa, which includes the molecular mass of the His-tag (5.6 kDa). The SDS-PAGE result ( Figure 6A ) showed that the target band of rBs-Omp31-BLS was consistent with the theoretical value. Western blot analysis ( Figure 6B ) showed that this protein band was recognized by the polyclonal antibody produced by rabbit after injection with purified rBs-Omp31-BLS (without His-tag). Figure 5A , Lane 1, total proteins of E. coli with pGEX-4T-1-omp31, without induction; lane 2, induction with 1 mM IPTG; lane 3, purified rBs-Omp31 protein, and lane M, standard protein marker. In Figure 5B, lanes 1, 2, and 3 , western blot lanes after immune recognition. Figure 6 . SDS-PAGE analysis of the recombinant expression of Bs-omp31-bls in Escherichia coli (A) and western blot analysis for rBs-Omp31-BLS after corresponding antibodyrecognition (B). In Figure 6A , lane 1, total proteins of E. coli with pET-28-a-Bs-omp31, without induction; lane 2, induction with 1 mM IPTG; lane 3, purified rOmp31-BLS protein, and lane M, standard protein marker. In Figure 6B, lanes 1, 2, 3 
Non-reducing SDS-PAGE results for polymerization of rBs-BLS molecule in vitro
Reformative non-reducing SDS-PAGE was used to detect the polymerization of rBs-BLS in vitro. When the first group was assayed, β-mercaptoethanol was not added to the sample. For the second group, boiling was not conducted. For the third group, both boiling and β-mercaptoethanol were eliminated. After non-reducing SDS-PAGE of proteins in the 3 groups, the proteins were electrically transferred onto a nitrocellulose membrane. Bands were detected using corresponding rabbit antiserum against rBs-BLS (without His-tag) in an immunoblotting assay. Finally, reformative non-reducing SDS-PAGE showed that rBs-BLS existed in different forms, including as a dimer and pentamer (Figure 7) . When β-mercaptoethanol was not added, proteins mainly remained as monomers. When boiling was not conducted, proteins also mainly remained as monomers. We speculated that most of the proteins were denatured under this condition. However, monomers decreased and dimer formation increased when both boiling and β-mercaptoethanol were eliminated, and pentamers began to appear (Figure 7 ). Some samples proteins may not have been denatured under this condition, and were thus able to polymerize. 
ELISA results of antibody titer assessment
To assess BLS aggregation for antigen proteins molecules during immune stimulation, ELISA was performed to detect the antibody titer. The results showed that the intact rOmp31-BLS fusion protein could stimulate much higher antibody levels than rOmp31 or rBLS protein. The absorbance value of rOmp31-BLS was nearly 6-fold higher than that of rBLS and 5-fold higher than that of rOmp31 (Figure 8) . Thus, the antibody titer of antiserum against rOmp31-BLS fusion protein was clearly higher than the antibody titer of antiserum against rOmp31 protein or rBLS protein. 
DISCUSSION
During the evolutionary process, bacteria that have established a chronic infection status in their hosts have developed a wide range of strategies to defend against and evade the host innate and adaptive immunity responses. Brucella is an intracellular bacteria and plays a direct pathogenic role in brucellosis. Although previous studies have aimed at improving brucellosis diagnosis techniques, the evaluation of alternative means of disease prevention have not been thoroughly examined. Subunit vaccines such as recombinant proteins are promising candidates because they are much safer, not infectious, and cannot revert to virulence. These problems are often observed in live attenuated vaccines. Proper selection of an immunogen would avoid a cross-reaction during diagnosis. Brucella Omps are ideal immunogens for subunit vaccine preparation. The rOmp31 from B. melitensis was found to stimulate antiserum production in sheep and ram (Estein et al., 2004) . Immunization of animals with B. ovis encoding for rOmp31 was reported to induce acceptable protection against B. ovis infection in immunized mice . Additionally, through the interaction with immunized rabbit serum, rOmp31 also reacted much more strongly than pre-immunized rabbit serum according to ELISA results (Ghasemi et al., 2013) . These data suggest that rOmp31 is a good candidate for subunit vaccine against Brucella. In the present study, the B. suis omp31 gene was cloned; this gene was 723 bp and did not contain a signal peptide sequence (Figure 2 ). After cloning into the E. coli pGEX-4T-1 expression vector, the B. suis omp31 gene was successfully expressed. The predicted molecular mass of rBs-Omp31 was 55.3 kDa, which included the molecular mass of the GST-tag (25 kDa) ( Figure 5A ). This rBs-Omp31 protein successfully stimulated rabbits to produce antiserum. Western blotting analysis showed that the rBs-Omp31 protein was specifically recognized by the corresponding rabbit antiserum ( Figure 5B ).
In addition, the bls gene has shown favorable immune-stimulation function. The incomplete fusion BLS-Omp31 protein vaccine elicited immune activation, which may be useful for effectively controlling canine brucellosis . However, an incomplete BLS molecule was previously fused with an incomplete Omp31 molecule. Thus, we cloned the intact B. suis bls gene, which was 477 bp without the signal peptide sequence (Figure 1 ). After cloning into the E. coli pET-28-a expression vector, intact B. suis bls gene was successfully expressed. The predicted molecular mass of rBs-BLS was 21 kDa, which included the molecular mass of His-tag (5.6 kDa) (Figure 3 ). This rBs-BLS protein successfully stimulated rabbits to produce antiserum. Western blotting analysis showed that the rBs-BLS protein was specifically recognized by the corresponding rabbit antiserum (Figure 4) . To study the polymerization of endogenous BLS, non-reducing SDS-PAGE was performed. The results showed that monomer formation rBLS was decreased and dimer formation was increased when both boiling and β-mercaptoethanol were not included. Additionally, pentamers began to form (Figure 7) . These results indicate that in Brucella, endogenous BLS can exist in at least 3 forms, that is, monomer, dimmer, and pentamer. The results also confirmed that the endogenous BLS molecule exerts its function in polymer form.
We also conducted a protein fusion assay in which we structured an omp31-bls fusion expression vector. After cloning into the E. coli pET-28-a expression vector, the omp31-bls fusion gene was successfully expressed. The predicted molecular mass of rBs-BLS was 49.4 kDa, which included the molecular mass of the His-tag (5.6 kDa) ( Figure 6A ). This Omp31-BLS fusion protein successfully stimulated the rabbit to produce antiserum. Western blotting analysis showed that the rOmp31-BLS fusion protein was specifically recognized by the corresponding rabbit antiserum ( Figure 6B ). To further examine the immunogenicity of the rOmp31-BLS fusion protein, ELISA was performed. The results showed that the intact rOmp31-BLS fusion protein could stimulate the production of much higher antibody levels than did the rOmp31 or rBLS proteins alone. According to the results of the t-test for the assay data, the antibody titer of antiserum against the rOmp31-BLS fusion protein was clearly higher than the antibody titer of antiserum against the rOmp31 protein or rBLS protein (Figure 8 ). rOmp31-BLS fusion showed an enhanced immune-stimulation effect, possibly because of the BLS molecule polymerizing function. After injection into rabbits, the rOmp31-BLS fusion protein may have been stimulated to form a polymer.
Omp31 showed positive results as a subunit vaccine candidate. This molecule stimulated the host to produce acceptable antiserum. After fusion with BLS, the immunogenicity of Omp31 was increased. The rOmp31-BLS fusion protein immunogenicity was related not only to immune stimulation by Omp31 but also to the polymerizing function of BLS.
